Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

scientific article

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1532-5415.2002.50455.X
P698PubMed publication ID12366617

P50authorCynthia L. LeibsonQ114081686
Jeanine E. RansomQ114104525
Anna N. A. TostesonQ110143968
L. Joseph MeltonQ112619624
P2093author name stringSherine E Gabriel
P2860cites workA new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes.Q33949350
Cerebral vascular accidents in patients over the age of 60. II. PrognosisQ34241339
History of the Rochester Epidemiology ProjectQ34374377
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesQ34439990
Decline in physical function following hip fractureQ39235646
How to predict return to the community after fractured proximal femur in the elderlyQ40793343
Modeling lifetime nursing home use under assumptions of better healthQ40849644
The aging of America. Impact on health care costsQ41192040
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis FoundationQ43583991
Cost-effective treatment strategies for osteoporosisQ44197505
Institutionalized patients with hip fractures: characteristics associated with returning to community dwelling.Q50551510
Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival.Q50872047
Cohort study of risk of institutionalisation after hip fracture.Q50960032
Extending Gerontological Research Through Linking Investigators' Studies to Public-Use DatasetsQ57695612
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectdisabilityQ12131
bone fractureQ68833
P304page(s)1644-1650
P577publication date2002-10-01
P1433published inJournal of the American Geriatrics SocietyQ6296094
P1476titleMortality, disability, and nursing home use for persons with and without hip fracture: a population-based study
P478volume50

Reverse relations

cites work (P2860)
Q82904019"N-active": a new comanaged, orthogeriatric ward: observations and prospects
Q498491623-T MR Imaging of Proximal Femur Microarchitecture in Subjects with and without Fragility Fracture and Nonosteoporotic Proximal Femur Bone Mineral Density
Q39465246A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures
Q44510314A cross-sectional study of the prevalence, correlates, and costs of falls in older home care clients 'at risk' for falling
Q37352516A new approach to menopausal therapy: the tissue selective estrogen complex
Q91286353A surrogate mechanostatistical microstructural model to inform whole hip cortical bone remodelling
Q37750520Addressing the age-related needs of osteoporotic patients with strontium ranelate
Q37436300An 8-week Aquatic Exercise Program is Effective at Improving Gait Stability of the Elderly
Q37672363An investigation of the association between omega 3 FA and bone mineral density among older adults: results from the National Health and Nutrition Examination Survey years 2005–2008.
Q37822779Antifracture efficacy of currently available therapies for postmenopausal osteoporosis
Q39671348Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway
Q46803164Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Q43727102Association between use of benzodiazepines and risk of fractures: a meta-analysis
Q51741457Association of air particulate pollution with bone loss over time and bone fracture risk: analysis of data from two independent studies.
Q90138490Atrial fibrillation and the risk of subsequent fracture
Q35229885BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS).
Q36461952Bayesian decision analysis for choosing between diagnostic/prognostic prediction procedures
Q33610208Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis
Q92639976Bipolar Hemiarthroplasty of Hip in an Unstable Angina Patient: A Case Report
Q33702810Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives
Q33851671Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project
Q34680563Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.
Q36700347Chronic Obstructive Pulmonary Disease Increases the Risk of Hip Fracture: A Nationwide Population-Based Cohort Study.
Q27016636Chronic proton pump inihibitor therapy and calcium metabolism
Q99615002Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk?
Q52594742Clinical Management of Osteoporotic Fractures.
Q39106834Cohort study evaluating the risk of hip fracture among patients with dementia in Taiwan.
Q58802680Comorbidities, clinical intercurrences, and factors associated with mortality in elderly patients admitted for a hip fracture
Q64323431Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
Q37085615Cost-effectiveness of bone densitometry among Caucasian women and men without a prior fracture according to age and body weight.
Q46553467Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
Q33282322Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
Q44227480Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study
Q37931985Current options for the management of postmenopausal osteoporosis
Q36696695DEXA screening--are we doing too much?
Q37685432Death, debility, and destitution following hip fracture
Q36683982Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk
Q37810423Denosumab for the Management of Postmenopausal Osteoporosis
Q46891538Depressive symptoms and fear of falling in previously community-dwelling older persons recovering from proximal femoral fracture
Q37199923Diagnosis and management of osteoporosis in the older senior
Q34667487Dietary acid load is not associated with lower bone mineral density except in older men
Q36172126Does cognitive/physical screening in an outpatient setting predict institutionalization after hip fracture?
Q35858255Dose-Effectiveness Relationships Determining the Efficacy of Ibandronate for Management of Osteoporosis: A Meta-Analysis
Q54542698Effect of occupational therapy on functional and emotional outcomes after hip fracture treatment: a randomized controlled trial.
Q41964250Effects of Tai Chi on balance and fall prevention in Parkinson's disease: a randomized controlled trial
Q37001665Effects of rabeprazole on bone metabolic disorders in a gastrectomized rat model
Q46767327Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women
Q33788826Emergency Department Pain Management Following Implementation of a Geriatric Hip Fracture Program
Q39045046Epidemiology and Postoperative Outcomes of Atypical Femoral Fractures in Older Adults: A Systematic Review
Q82723971Epidemiology of osteoporosis
Q35015878Evaluation of the effect of a comprehensive multidisciplinary care pathway for hip fractures: design of a controlled study
Q36620541Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate
Q35120734Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
Q40032001Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study
Q36406647Factors associated with mortality following hip fracture in Japan
Q37401866Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing
Q35949189Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women
Q37732469Feasibility of three-dimensional MRI of proximal femur microarchitecture at 3 tesla using 26 receive elements without and with parallel imaging.
Q38236887Fracture mortality: associations with epidemiology and osteoporosis treatment
Q35194455Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients
Q58757367Fracture risk assessment in home care patients using the FRAX® tool
Q46068063Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates
Q91810820Fragility Fracture Prevention-Implementing a Fracture Liaison Service in a High Volume Orthopedic Hospital
Q35953426Frailty and Short-Term Outcomes in Patients With Hip Fracture
Q47732600Health Risk Perceptions and Exercise in Older Adulthood: An Application of Protection Motivation Theory
Q53282553Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos).
Q39493451High Levels of Geriatric Palliative Care Needs in Hip Fracture Patients Before the Hip Fracture
Q34599603Higher fish intake is associated with a lower risk of hip fractures in Chinese men and women: a matched case-control study
Q36623119Hip fracture and increased short-term but not long-term mortality in healthy older women
Q33837287Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009
Q51916742Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical, cognitive, and socioeconomic indicators.
Q26829440Hip fractures in a geriatric population - rehabilitation based on patients needs
Q44612757Hip fractures in institutionalized elderly people: incidence rates and excess mortality
Q46232408Hip fractures in the United States: 2008 nationwide emergency department sample
Q37049150Hip structural analysis: a comparison of DXA with CT in postmenopausal Japanese women
Q24651058History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans
Q48251787Home, please: A conjoint analysis of patient preferences after a bad hip fracture
Q36533644Hormone therapy: maximizing the benefits
Q40126151Impact of malnutrition on 12-month mortality following acute hip fracture
Q33644466Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program
Q91822207In vitro injection of osteoporotic cadaveric femurs with a triphasic calcium-based implant confers immediate biomechanical integrity
Q41917351Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss
Q50055457Incidence Rates of and Mortality after Hip Fracture among German Nursing Home Residents
Q49322761Incidence and mortality of fractures by frailty level over 80 years of age: cohort study using UK electronic health records.
Q38896852Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study.
Q40551201Incident atrial fibrillation and the risk of fracture in the cardiovascular health study
Q36285963Incorporating quality of evidence into decision analytic modeling
Q45167061Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications
Q94547176Individual and joint trajectories of change in bone, lean mass and physical performance in older men
Q33321341Individual nutrition therapy and exercise regime: a controlled trial of injured, vulnerable elderly (INTERACTIVE trial)
Q42684289Initiation of antihypertensive monotherapy and incident fractures among Medicare beneficiaries
Q36127633Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research
Q35953419Is Scheduled Intravenous Acetaminophen Effective in the Pain Management Protocol of Geriatric Hip Fractures?
Q92101018Key Service Improvements After the Introduction of an Integrated Orthogeriatric Service
Q64106339Large cortical bone pores in the tibia are associated with proximal femur strength
Q33614562Linking the Iowa Women's Health Study cohort to Medicare data: linkage results and application to hip fracture.
Q37919556Literature review: using pictographs in discharge instructions for older adults with low-literacy skills
Q36421367Long term health outcomes after injury in working age adults: a systematic review
Q48951409Long-term effects of home rehabilitation after hip fracture - 1-year follow-up of functioning, balance confidence, and health-related quality of life in elderly people
Q36876802Long-term mortality following injury in working-age adults: a systematic review.
Q41681791MORTALITY AND FUNCTION AFTER SURGICALLY-TREATED HIP FRACTURE IN ADULTS YOUNGER THAN AGE 60.
Q38761009MRI assessment of bone structure and microarchitecture.
Q92356877MRI-derived bone porosity index correlates to bone composition and mechanical stiffness
Q64107628Management of Fragility Hip Fractures: Our Institutional Experience
Q37337113Management of osteoporosis in the aging male: focus on zoledronic acid
Q26824069Maximising functional recovery following hip fracture in frail seniors
Q33503680Medial hip neck fracture: influence of pre-operative delay on the quality of outcome. Results of data from the external in-hospital quality assurance within the framework of secondary data analysis
Q38920718Medical management of osteoporosis and the surgeons' role
Q35886848Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture
Q58433670Minimally invasive anterior muscle-sparing versus a transgluteal approach for hemiarthroplasty in femoral neck fractures-a prospective randomised controlled trial including 190 elderly patients
Q34014211Mortality and osteoporotic fractures: is the link causal, and is it modifiable?
Q36283404Municipal resources and patient outcomes through the first year after a hip fracture
Q36671394Myocardial infarction after hip fracture repair: a population-based study
Q37842737New treatment approach for osteopenia
Q88231775Numerical investigation of the effect of bone cement porosity on osteoporotic femoral augmentation
Q33220023On the prognosis of hip fractures. Assessment of mortality after hip fractures by analyzing overlapping segments of longitudinal data
Q38669033OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects
Q58698204Optimization the Initial Weights of Artificial Neural Networks via Genetic Algorithm Applied to Hip Bone Fracture Prediction
Q38126393Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis
Q26738519Orthogeriatric care: improving patient outcomes
Q79299225Osteoporosis
Q26824690Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications
Q38002942Osteoporosis and osteopenia: implications for periodontal and implant therapy
Q46865059Osteoporosis in the elderly
Q56785994Osteoporotic hip fractures in non-elderly patients: relevance of associated co-morbidities
Q38576989Osteoporotic hip fractures: 10-year review in a Singaporean hospital
Q37807918Outcome in geriatric fracture patients and how it can be improved
Q39077620Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility Fractures.
Q36793560Panoramic images of white and black post-menopausal females evidencing carotid calcifications are at high risk of comorbid osteopenia of the femoral neck
Q33850387Patient safety in elderly hip fracture patients: design of a randomised controlled trial
Q39029467Patient-specific Hip Fracture Strength Assessment with Microstructural MR Imaging-based Finite Element Modeling.
Q30811657Patients with femoral or distal forearm fracture in Germany: a prospective observational study on health care situation and outcome
Q39455613Pharmacological treatment of osteoporosis in the oldest old.
Q34974773Physical activity and hip fracture disability: a review
Q36590218Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: the Framingham Osteoporosis Study
Q37448214Polyunsaturated fatty acids and their relation with bone and muscle health in adults.
Q36315408Postacute rehabilitation care for hip fracture: who gets the most care?
Q40392736Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy
Q79184483Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy
Q88636789Practical points in the medical treatment of overactive bladder and nocturia in the elderly
Q53061961Pre-discharge home visits by occupational therapists completed for patients following hip fracture.
Q35186518Precision of volumetric assessment of proximal femur microarchitecture from high-resolution 3T MRI.
Q40975843Predictive factors of adverse events after intravesical suburothelial onabotulinumtoxina injections for overactive bladder syndrome-A real-life practice of 290 cases in a single center
Q35681100Predictors of functional outcome following femoral neck fractures treated with an arthroplasty: limitations of the Harris hip score
Q33914532Prevalence and Risk Factors of Osteoporosis Among Jordanian Postmenopausal Women Attending the National Center for Diabetes, Endocrinology and Genetics in Jordan
Q46381412Prevalence of vertebral fracture in elderly men and women with osteopenia
Q37417515Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application.
Q38778102Prophylactic augmentation of the osteoporotic proximal femur-mission impossible?
Q40659849Prospective study of predictive factors of changes in pain and hip function after hip fracture among the elderly.
Q30881569Protective effect of bisphosphonates on endometrial cancer incidence in data from the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
Q91963630Proximal Femur Hounsfield Units on CT Colonoscopy Correlate With Dual-energy X-ray Absorptiometry
Q40732563Proximal femur geometry assessed by hip structural analysis in hip fracture in women
Q49306564Quality of life and psychological consequences in elderly patients after a hip fracture: a review.
Q37346101Quarterly intravenous ibandronate for postmenopausal osteoporosis
Q53731159Radiographic study of the proximal femur morphology of elderly patients with femoral neck fractures: is there a difference among ethnic groups?
Q37126681Recent hospitalization and the risk of hip fracture among older Americans.
Q48427955Recovery of function following a hip fracture in geriatric ambulatory persons living in nursing homes: prospective cohort study
Q64231756Regaining Versus Not Regaining Function Following Hip Fracture-A Descriptive Study
Q24240347Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people
Q24240428Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people
Q24242170Rehabilitation interventions for improving physical and psychosocial functioning after hip fracture in older people
Q48301823Relation between Spongy Bone Density in the Maxilla and Skeletal Bone Density.
Q61941678Relative survival after hospitalisation for hip fracture in older people in New South Wales, Australia
Q41585378Reliability and validity of the Falls Efficacy Scale-International after hip fracture in patients aged ≥ 65 years
Q58543140Residual Disability, Mortality, and Nursing Home Placement after Hip Fracture over Two Decades
Q34004364Rethinking guidelines for VTE risk among nursing home residents: a population-based study merging medical record detail with standardized nursing home assessments.
Q36430746Retrospective evaluation versus population norms for the measurement of baseline health status
Q53128627Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Q35857544Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study
Q33741249Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study
Q64269246Risk of imminent fracture following a previous fracture in a Swedish database study
Q64977310Risk of subsequent fracture after prior fracture among older women.
Q38033250Role of comprehensive geriatric assessment in the management of osteoporotic hip fracture in the elderly: an overview
Q35026446Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
Q41137591Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US Medicare perspective
Q36601333Senior Managed Care System for Hip Fracture in the United States
Q43843406Severity of cognitive impairment as a prognostic factor for mortality and functional recovery of geriatric patients with hip fracture
Q36580612Sex-specific differences in progressive glucose intolerance and hip geometry: the Baltimore Longitudinal Study of Aging
Q61453667Short-Term Outcomes of Interdisciplinary Hip Fracture Rehabilitation in Frail Elderly Inpatients
Q37469982Social support for exercise by experts in older women post-hip fracture
Q36954913Stability and Change in Activities of Daily Living Among Older Mexican Americans
Q35627029Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study.
Q36683942The 1-year mortality of patients treated in a hip fracture program for elders
Q80833944The 24-h distribution of falls and person-hours of physical activity in the home are strongly associated among community-dwelling older persons
Q37856217The 25th anniversary of BUA for the assessment of osteoporosis: time for a new paradigm?
Q88955809The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients
Q90194817The Increase of Osteoporotic Hip Fractures and Associated One-Year Mortality in Poland: 2008-2015
Q34136768The Influence of Short-term Aquatic Training on Obstacle Crossing in Gait by the Elderly
Q37432366The aftermath of hip fracture: discharge placement, functional status change, and mortality.
Q37730447The burden of second hip fractures: provincial surgical hospitalizations over 15 years.
Q33741164The development of a comprehensive multidisciplinary care pathway for patients with a hip fracture: design and results of a clinical trial
Q33396370The effect of time-to-surgery on outcome in elderly patients with proximal femoral fractures
Q40509187The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture
Q58803168The epidemiology and economic burden of hip fractures in Israel
Q36569605The evolving role of exemestane in the management of breast cancer
Q34590994The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications
Q36006677The need for microsimulation to evaluate osteoporosis interventions.
Q34251696The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system
Q42839510The role of the nurse in the management of osteoporosis
Q37230573The second hip fracture in osteoporotic patients: not only an orthopaedic matter
Q34110560The synergistic effect of functional status and comorbidity burden on mortality: a 16-year survival analysis.
Q39724622The treatment of osteopenia in Asian women: a new approach
Q47766890Thinking falls-taking action: a falls prevention tool for care homes.
Q51183098Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration.
Q37768158Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms
Q92188147Tobacco and bone fractures: A review of the facts and issues that every orthopaedic surgeon should know
Q83706992Trajectories of functional change among long stayers in nursing homes: does baseline impairment matter?
Q35229889Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007
Q36580627Type 2 diabetes and bone fractures
Q37639402Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
Q35719101Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study
Q45091227Use of strontium as a treatment method for osteoporosis
Q48050798Validation of the Malay version of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) in Malaysia
Q48222095What determines health-related quality of life in hip fracture patients at the end of acute care?--a prospective observational study
Q44787178Withholding clopidogrel for 3 to 6 versus 7 days or more before surgery in hip fracture patients
Q82238896[Acute orthogeriatric care (II). Clinical aspects]
Q50760664[Hip fracture incidence in an urban area in Northeast Brazil].
Q79197119[The elder patient with a rheumatic disease and comorbidities. Aspects of rheumatology in an ageing population]

Search more.